China Hospital Priorities — Strategic Themes and Implications for Medtechs Presentations September 18, 2020 Stephen Sunderland Helen Chen
Related Practice Life Sciences & Pharma Healthcare Services MedTech L.E.K., in collaboration with APACMed, conducted a survey with ~400 hospital executives across both public and private hospitals in key APAC markets. 06302022090649
Executive Insights Contract/Pharma Services Key Trends for CDMOs Partnering With Cell Therapy Developers July 11, 2024
Case Study Life Sciences & Pharma Cost and Reimbursement Assessment for a Biopharmaceutical Company May 7, 2024 A large biopharmaceutical company developing chimeric antigen receptor T-cell (CAR-T) therapies
Case Study Biotech and Pharmaceuticals Reimbursement Assessment for a Therapy for Hemodialysis Patients May 3, 2024 A biopharmaceutical company with a novel treatment of chronic kidney disease-associated pruritus asked L.E.K. to assess the potential risk of bundling of…
Case Study Biotech and Pharmaceuticals Pricing Strategy for a Recently Commercialized Rheumatoid Arthritis Drug April 30, 2024 A biopharma company with a recently launched rheumatoid arthritis drug asked L.E.K. Consulting to define the optimal price strategies for the 12-18 months…
Article Mental and Behavioral Health Exploring the Psychedelics Landscape: Looking Ahead to Funding in 2024 February 20, 2024
Published Articles Biotech and Pharmaceuticals EU Pharmaceutical Legislation Revisions: What Are the Implications for Biopharma? December 20, 2023